Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
DEL PRIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionEverSource Wealth Advisors, LLC
Latest Disclosed Ownership25,896 shares
Latest Disclosed Value $ 479,601
EverSource Wealth Advisors, LLC reports 95.78% increase in ownership of TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - EverSource Wealth Advisors, LLC filed a 13F-HR/A form disclosing ownership of 25,896 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $409,157 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 13,227 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of 95.78% during the quarter. The current value of the position is $331,469 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F/A-1 TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 25,896 12,669 95.78 480 132.52 0.0022
2026-05-14 2026-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,234 -10,993 158 0.0048
2026-02-06 2025-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 13,227 -3,700 -21.86 206 -16.60 0.0076
2025-11-10 2025-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 16,927 850 5.29 248 -0.40 0.0098
2025-08-13 2025-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 16,077 9,536 145.79 249 155.67 0.0112
2025-05-13 2025-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 6,541 1,351 26.03 97 42.65 0.0053
2025-02-10 2024-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 5,190 1,770 51.75 69 41.67 0.0039
2024-11-08 2024-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 3,420 338 10.97 49 14.29 0.0031
2024-08-13 2024-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 3,082 859 38.64 43 44.83 0.0028
2024-06-11 2024-03-31 13F/A-1 TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 2,223 656 41.86 29 31.82 0.0023
2024-05-13 2024-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,567 0 22 0.0008
2024-02-09 2023-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,567 135 9.43 22 0.00 0.0020
2023-11-03 2023-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,432 167 13.20 22 15.79 0.0023
2023-08-04 2023-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,265 -492 -28.00 20 -32.14 0.0022
2023-05-11 2023-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,757 728 70.75 29 75.00 0.0036
2023-02-09 2022-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,029 -2,286 -68.96 16 -62.79 0.0024
2022-11-07 2022-09-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 3,315 -3,175 -48.92 43 -52.75 0.0098
2022-08-01 2022-06-30 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 6,490 5,070 357.04 91 355.00 0.0235
2022-05-25 2022-03-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 1,420 1,326 1,410.64 20 1,900.00 0.0051
2022-02-17 2021-12-31 13F/A-1 TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 94 94 1 0.0003
2022-02-07 2021-12-31 13F TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS ADR 874060205 94 94 1 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.